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Editorial
Chronic kidney disease (CKD) is a global health 
crisis, with an estimated prevalence of 8-16% 
worldwide.1 In people aged 65-74, 1 in 5 men and 
1 in 4 women have CKD. Well-known complications of 
acute and chronic kidney disease include cardiovascular 
disease and death, end stage renal disease (ESRD), 
infections, mineral and bone disorders, anemia, and 
cognitive decline. What may be underappreciated is 
that kidney disease is deadly, consistently reported as 
the 9th leading cause of death in the United States.2 
In fact, more than 90,000 Americans die from kidney 
diseases annually, which exceeds the number of 
combined deaths from breast and prostate cancer. 
Yet how often do pathologists invoke kidney disease 
as the cause of death at autopsy? Are pathologists 
adequately trained to recognize medical renal diseases 
in autopsy specimens? Since kidney biopsy is usually 
avoided in critically ill patients, histologic evaluation of 
autopsy kidneys may be the first and only opportunity 
to identify these diseases. This is crucial as these 
findings may have implications for the surviving family 
members, particularly for those diseases with a genetic 
component.
We recently conducted a retrospective histologic 
review of adult autopsy kidneys at our institution 
in order to 1) establish a baseline of medical renal 
diseases which the autopsy pathologist can expect to 
encounter, and 2) determine the incidence of missed 
diagnoses. In addition to frequent findings of acute 
tubular injury and arterionephrosclerosis, we detected a 
wide variety of significant renal pathology in one-third 
of adult autopsies over a 2-year span.3 Common 
lesions included diabetic nephropathy, thrombotic 
microangiopathy, glomerulonephritis (frequently 
infection-related), diseases related to underlying 
hematologic malignancies, and toxic/metabolic 
tubulointerstitial diseases. Review of the corresponding 
autopsy reports reveals that most of these lesions (60%) 
were not identified. Unfortunately, this deficiency was 
not surprising given the recent literature demonstrating 
that nonneoplastic renal diseases are often missed in 
tumor nephrectomy specimens.4-8
There are several possible reasons why a 
pathologist might commit a diagnostic error by 
overlooking a disease process at autopsy. The primary 
emphasis during autopsy examination is identification 
of the immediate cause of death, which results in a 
more dedicated examination of the organs frequently 
involved in devastating events (i.e. heart, lungs, and 
brain). Surgical pathology practices have become 
increasingly subspecialized, so pathologists are also 
likely to focus on their organ system(s) of expertise. 
We also speculate that many pathologists are not 
adequately trained to recognize medical diseases in 
autopsy kidney specimens. Our study demonstrates 
a knowledge gap that needs to be addressed, and 
also provides a mechanism for addressing it. Autopsy 
pathology, including medical renal pathology, is a rich 
educational resource that should be emphasized in 
residency training.
The deficiency in knowledge regarding renal 
pathology is most likely due to limited exposure and 
the current training practices in pathology residency 
programs. In an effort to address this deficiency in the 
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US, the Accreditation Council for Graduate Medical 
Education (ACGME) included the requirement of renal 
pathology in the anatomic pathology curriculum for 
pathology residents effective July 1, 2015. One of 
the challenges in developing a renal pathology 
curriculum to meet the ACGME requirement is the 
perceived scarcity of teaching material. Medical 
renal pathology is a small and highly subspecialized 
field, requiring integration of clinical and laboratory 
data with light, immunofluorescence, and electron 
microscopic techniques. Kidney biopsy services and 
fellowship-trained nephropathologists are typically 
centralized in large academic pathology departments. 
Institutions with smaller pathology programs may 
struggle to develop a renal pathology curriculum. 
Our study provides one solution to this problem 
by establishing autopsy kidney specimens as a rich 
source of medical renal pathology for diagnostic and 
teaching purposes. In fact, autopsy kidneys likely 
provide a more accurate picture of the spectrum and 
frequency of kidney disease in the general population 
than for-cause renal biopsies. Based on our own 
departmental experience, we advocate a dedicated 
renal pathology rotation early in residency training, 
followed by reinforcement over subsequent years 
through one-on-one review of autopsy kidneys and the 
non-neoplastic parenchyma in tumor nephrectomies 
with renal pathologists. Autopsy kidneys can easily 
be incorporated into didactic lectures and unknown 
slide sessions, particularly in residency programs with 
fewer medical renal biopsies. Our implementation of 
this curriculum has met with great success and positive 
feedback.
There are certain challenges to assessment of the 
kidneys at autopsy, particularly given the desire to 
minimize costs, and no standard guidelines have been 
established for their proper evaluation. Several recent 
reviews have detailed suggested approaches to autopsy 
renal pathology including gross examination, tissue 
allocation, and ancillary studies, in addition to medical 
record review.9,10 We would emphasize the importance 
of systematic evaluation of all four compartments 
of renal parenchyma on the H&E stain, namely the 
glomeruli, tubules, interstitium, and vessels. In fact, 
most lesions can be identified or strongly suspected 
based on H&E staining alone, precluding the time and 
cost of ancillary studies.
Unfortunately, the value placed on the autopsy 
has declined over the past few decades due to a 
combination of factors including lack of reimbursement, 
clinical disinterest, advances in premortem diagnostic 
techniques, and risk of litigation. Autopsy rates 
dropped precipitously in the US after the Joint 
Commission on Accreditation discontinued their 
hospital autopsy mandate in 1971 and Medicare 
stopped reimbursement in 1986. Many physicians are 
concerned that current hospital autopsy rates have 
declined to approximately 10% of hospital deaths,11,12 
down from a 70% or higher rate in teaching hospitals 
in the 1960s.13 It has been well-documented that the 
hospital autopsy provides invaluable epidemiological 
data and significantly contributes to quality control 
and improvement of patient care.11,14-16 In the 
College of American Pathologists Q-Probes Study,17,18 
an unexpected disease finding that contributed 
to a patient’s death was identified in 39.7% of 
2479 autopsies from 248 institutions. The same study 
also determined that 93.0% of clinical questions were 
resolved by the autopsy. In addition to the clinical 
relevance of the postmortem examination in current 
medical practice, the hospital autopsy provides a 
valuable educational tool for both residents and medical 
students. The autopsy epitomizes problem-based 
learning and clinicopathologic correlation as well 
as providing valuable material for learning gross 
and histologic examination, including medical renal 
pathology. Encouragingly, both internal medicine 
and pathology residents at a large academic teaching 
hospital assign high importance to autopsies in terms 
of education, answering clinical questions, public 
health, and research.19 It is imperative that academic 
pathologists emphasize the value of the autopsy to 
our pathologists-in-training.
Our institutional review highlights a knowledge 
gap that is pertinent to all practicing pathologists, 
who should be aware that medical renal disease 
is common in adult autopsy kidney specimens but 
is often overlooked. The autopsy has long been 
recognized for providing important contributions in 
medical education and quality improvement of care, 
and autopsy kidney specimens are a valuable source of 
material to supplement training in anatomic pathology. 
Furthermore, our understanding of the natural history 
and pathogenesis of kidney disease will improve with 
accurate recognition and reporting of kidney diseases 
at autopsy.
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